Geode Capital Management
AMAM

Geode Capital Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Geode Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-81,157
Closed -$1.16M – 4673
2023
Q4 		$1.16M Buy
81,157
+31,017
+62% +$352K ﹤0.01% 3301
2023
Q3 		$577K Buy
50,140
+10,702
+27% +$146K ﹤0.01% 3542
2023
Q2 		$649K Buy
+39,438
New +$496K ﹤0.01% 3530

Geode Capital Management's AMAM Position: Q1 2024 in Review

Geode Capital Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 81,157 shares — an estimated $1.16M sold.

Geode Capital Management first reported a position in AMAM in Q2 2023 and held it in 3 quarters. The position peaked at $1.16M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Geode Capital Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 81,157 Ambrx Biopharma Inc shares in Q1 2024, an estimated $1.16M.
  • Geode Capital Management first reported a position in Ambrx Biopharma Inc in Q2 2023 and held it in 3 quarters.
  • Geode Capital Management's Ambrx Biopharma Inc position peaked at $1.16M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.